In Memory of Lawrence H. Cohn, MD
It is with great sadness we share that Lawrence H. Cohn, MD, a pioneering cardiac surgeon and devoted educator, former chair of the Division of Cardiac Surgery and the Virginia and James Hubbard Chair in Cardiac Surgery at Harvard Medical School passed away on Saturday evening.
Over nearly 45 years at BWH, Dr. Cohn has left an indelible stamp on the Brigham, helping to position the hospital as a leader in minimally invasive cardiac surgery and training scores of surgeons, many of whom have become national leaders in the field...(continued)
NATF 10th Anniversary Celebration
REGISTRATION IS OPEN
Thursday March 10, 2016 • 6 PM - 9 PM
The Mandarin Oriental Hotel, Boston, MA
Join us for one inspiring evening to celebrate a decade of fighting blood clots and saving lives through prevention and education.
Evening will include a lovely cocktail reception, a raffle with both big and small items to be won, and a delicious dinner catered by the Mandarin Oriental Hotel. More information
Please enjoy this exciting 60-second video of some of NATF's key players discussing our upcoming 10th Anniversary Event!
2016 SPRING PATIENT PROGRAM
Call to Action to Prevent Thrombosis:
Power to the Patient
Wednesday, April 6
4:30 PM - 8:30 PM
Joseph B. Martin Conference Center, Boston, MA
Our newly designed program exclusively for patients! This program is aimed at providing patients with the knowledge they need to prevent thrombosis and improve their cardiovascular health. Four experts in the field of Thrombosis Medicine will share updates from breakthrough research being done on serious conditions involving blood clots such as heart attack, stroke as a result of atrial fibrillation, pulmonary embolism, and deep vein thrombosis.
Three patient survivors of major thrombotic events will discuss everything from their symptoms and diagnosis through to their recovery and life after a thrombotic event. Reserve your seat now!
DVT/PE TREATMENT OPTIONS
How do healthcare providers decide which treatments are the best option for their patients? Read this article to find out more about DVT/PE treatment goals, options, risks, and decision-making.
For many years, Warfarin was the only oral anticoagulant commonly used to treat blood clots. In the past five years, the FDA has approved four new oral anticoagulants for the treatment of DVT, PE, and SPAF. Find out the differences between the five FDA-approved oral anticoagulants. View the Chart.